Gossamer Bio

Gossamer Bio is a clinical-stage biopharmaceutical company based in San Diego that specializes in the discovery, development, and commercialization of innovative therapeutic products targeting significant unmet medical needs. Founded by former executives from Receptos, the company focuses on areas such as immunology, inflammation, fibrosis, and oncology. Its pipeline includes several promising candidates: Seralutinib, aimed at addressing pulmonary arterial hypertension; GB004, for inflammatory bowel disease; GB1275, targeting various oncology indications; and GB001, designed for moderate-to-severe eosinophilic asthma. Gossamer Bio's strategy involves leveraging a rich in-licensing environment to enhance its therapeutic offerings, supported by a team recognized for their successful track record in drug development.

Rainer Zimmermann

VP of Medical Affairs

1 past transactions

Adhaere Pharmaceuticals

Acquisition in 2019
Adhaere Pharmaceuticals is a biopharmaceutical company based in Skokie, Illinois, specializing in the development of novel therapeutics. The company aims to target adhesion receptors on leukocytes to create a pipeline of targeted drugs. These therapeutics are designed to address significant unmet medical needs in various areas, including solid tumors, inflammatory diseases, and autoimmune diseases. Through its innovative approach, Adhaere Pharmaceuticals seeks to advance treatment options for patients suffering from these serious health conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.